Gene expression and cellular profiling in a rat bleomycin model of drug-induced interstitial lung disease (DIILD)

I. Mahmutovic Persson (Lund, Sweden), N. Fransén Pettersson (Lund, Sweden), J. Liu (Lund, Sweden), H. Falk-Håkansson (Lund, Sweden), L. Olsson (Lund, Sweden), K. Wachenfeldt (Lund, Sweden)

Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Session: Mechanistic insight into lung injury and repair
Session type: E-poster session
Number: 573
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Mahmutovic Persson (Lund, Sweden), N. Fransén Pettersson (Lund, Sweden), J. Liu (Lund, Sweden), H. Falk-Håkansson (Lund, Sweden), L. Olsson (Lund, Sweden), K. Wachenfeldt (Lund, Sweden). Gene expression and cellular profiling in a rat bleomycin model of drug-induced interstitial lung disease (DIILD). 573

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Homeobox-genes (HOX) in human lung - altered expression in lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001

A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015


Biological- and imaging biomarkers of edema and fibrosis in a rat model of drug-induced interstitial lung disease (DIILD)
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Strong reversal of the lung fibrosis disease signature by autotaxin inhibitor GLPG1690 in a mouse model for IPF
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016



SMAD2 mRNA expression is upregulated in fibrosing interstitial lung diseases (ILDs)
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Effect of Nintedanib in a rat model of bleomycin-induced lung fibrosis: a transcriptome analysis
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


Gene expression patterns in lung emphysema. A gene microarray analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 87s
Year: 2002

Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model
Source: ERJ Open Res, 7 (4) 00345-2021; 10.1183/23120541.00345-2021
Year: 2021



Nintedanib inhibits fibroblast activation and ameliorates pulmonary and dermal fibrosis in models of systemic sclerosis (SSc)
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Expression profiling of genes differentially regulated under hyperoxia andmechanical ventilation in mouse model of neonatal chronic lung disease
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019

Beryllium-induced lung disease exhibits expression profiles similar to sarcoidosis
Source: Eur Respir J 2016; 47:1797-1808
Year: 2016



Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015

Multiplex and gene expression analysis in a model of smoke induced lung inflammation in mice
Source: Eur Respir J 2005; 26: Suppl. 49, 104s
Year: 2005

Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


The effects of tobramycin on pulmonary fibroblast function
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


Gene expression profiling: can we identify the right target genes?
Source: Eur Respir Rev 2008; 17: 163-167
Year: 2008



Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling.
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018